Showing posts with label bby. Show all posts
Showing posts with label bby. Show all posts

Tuesday, June 16, 2009

Earnings - 16th June 2009

4:06PM Adobe Systems reports EPS in-line, beats on revs; guides Q3 EPS in-line (ADBE) 28.17 -0.65 : Reports Q2 (May) earnings of $0.35 per share, in-line with the First Call consensus of $0.35; revenues fell 20.5% year/year to $704.7 mln vs the $694.8 mln consensus. Co issues in-line guidance for Q3, sees EPS of $0.30-0.37 vs. $0.33 consensus.

9:31AM Life Partners Holdings sees Q1 EPS of $0.53 vs $0.54 single analyst est (LPHI)17.22 +0.38 : Co issues downside guidance for Q1 (May), sees EPS of $0.53 vs. $0.54 single analyst est; sees Q1 (May) revs of $27.4 mln vs. $29.50 mln single analyst est. Co says "We are continuing to see growth within the life settlement industry and, as a leader in this industry, we are continuing to grow as well. As the financial markets remain turbulent, we expect the interest in life settlements to continue. This is because the gains from life settlements come from the inherent value in these policies and not from market appreciation..."

9:08AM Nucor guides Q2 loss slightly better than consensus (NUE) 45.75 : Co issues guidance for Q2 (Jun), sees EPS of ($0.65)-($0.55) vs. ($0.69) First Call consensus. Co said, "Order entry has improved in recent weeks. Nevertheless, the economic outlook remains very uncertain in light of the continuing severe structural challenges facing the U.S. and global economies. We believe this period of economic and steel industry distress will present unusually attractive growth opportunities for Nucor."

9:03AM STEC Inc raises guidance above consensus for Q2 (STEC) 18.02 : Co raises guidance for Q2 (Jun), sees EPS of $0.32-0.36 vs. $0.21 First Call consensus, prior guidance $0.20-0.22; sees Q2 (Jun) revs of $82-84 mln vs. $69.05 mln consensus, prior guidance $68-70 mln. The increased Non-GAAP diluted earnings per share and revenue guidance are primarily the result of increases in the Company's ZeusIOPS sales which now are estimated to exceed $55 million during the second quarter of 2009. The Company had previously estimated revenue from ZeusIOPS SSDs to surpass $65 million during the first half of 2009. With this increase in revenue, the Company now expects ZeusIOPS SSD sales to exceed $80 million during the first half of 2009. (Stock is halted.)

8:35AM Providence Service Corp expects Q2 EPS of at least $0.36 vs $0.38 First Call consensus (PRSC) 9.78 : Co says, "We continued to see operating results strengthen in April and May. The payer environment continues to stabilize, Medicaid enrollment is increasing, and the benefits of recent cost cutting programs continued to enhance our results in the second quarter."

8:07AM Best Buy beats by $0.08, reports revs in-line; comparable store sales -6.2%; reaffirms FY10 EPS guidance (BBY) 38.66 : Reports Q1 (May) earnings of $0.42 per share, ex items, $0.08 better than the First Call consensus of $0.34; revenues rose 12.3% year/year to $10.1 bln vs the $10.13 bln consensus. Co reports -6.2% comparable store sales for Q1. The company noted that while traffic trends showed less volatility in the fiscal quarter, domestic comparable store sales declines were highest during the month of May as the company faced difficult comparisons versus the impact of government stimulus checks issued in the prior year. The company had previously indicated that it anticipates comparable store sales declines to be greater during the fiscal first half of the year than the second half. The company said it believes its domestic segment market share gains accelerated in the quarter, growing nearly 200 basis points for the three months ending April 30, 2009. These better-than-expected market share gains were led by notebook computers, flat-panel televisions, digital imaging and mobile phones. Market share gains accelerated in March and April as the company realized benefits from changes in the competitive environment as well as from transitions to new product models accomplished earlier than its competition. Co reaffirms guidance for FY10, sees EPS of $2.50-2.90 vs. $2.79 consensus.

7:05AM Smithfield Foods beats by $0.05, misses on revs (SFD) 11.18 : Reports Q4 (Apr) loss of $0.55 per share, $0.05 better than the First Call consensus of ($0.60); revenues fell 0.6% year/year to $2.85 bln vs the $3.06 bln consensus. Co said, "We are constantly evaluating options associated with pushing off near term maturities, seeking permanent covenant relief and reducing our overall debt levels. Toward that end, I am pleased to report that we are continuing discussions regarding refinancing with various lenders, well in advance of current maturities. In addition, we have made significant progress on improving our balance sheet, reducing debt and increasing liquidity... As we move into fiscal 2010, our highest priority is on continuing the restructuring of the Pork Group, continuing to reduce debt, improving liquidity and strengthening the balance sheet... We believe that the A(H1N1) virus had only a short-term effect on U.S. fresh pork demand, which hurt our business last month".

7:04AM FactSet beats by $0.01, reports revs in-line; guides Q4 EPS above consensus, revs in-line (FDS) 50.92 : Reports Q3 (May) earnings of $0.73 per share, excluding an income tax benefit, $0.01 better than the First Call consensus of $0.72; revenues rose 4.7% year/year to $154.4 mln vs the $155.2 mln consensus. Co issues mixed guidance for Q4, sees EPS of $0.73-0.75 vs. $0.72 consensus; sees Q4 revs of $152-157 mln vs. $155.45 mln consensus. Co's Q3 operating margins rose to 34.5%.

Friday, January 9, 2009

Earnings - 9th Jan 2009

9:02AM Stryker guides revs in-line for Q4, reaffrirms FY08 EPS guidance; issues in-line guidance for FY09 (SYK) 38.58 : Co issues in-line guidance for Q4 (Dec), sees Q4 (Dec) revs of $1.718 bln vs. $1.7 bln First Call consensus. Co reaffirms guidance for FY08 (Dec), sees EPS of $2.82-2.84 vs. $2.83 consensus. Co issues in-line guidance for FY09 (Dec), sees EPS of $3.12-3.22 vs. $3.15 consensus.

8:36AM CVS Caremark guides below consensus for Q1 & FY09 (CVS) 29.34 : Co issuesdownside guidance for Q1 (Mar), sees EPS of $0.53-0.55 vs. $0.63 First Call consensus. Co issues downside guidance for FY09 (Dec), sees EPS of $2.53-2.61 vs. $2.74 consensus.

8:01AM AsiaInfo lowers EPS guidance, raises rev guidance; sees Q4 EPS of $0.03-0.04 vs $0.17 consensus; revs $48-51 mln vs $48.16 mln consensus (ASIA) 10.98 : Co sees Q4 EPS of $0.03-0.04 including recognition of $6.6 mln, or $0.15 per basic share, non-cash impairment charges to earnings in Q4 of 2008 related to certain short-term investments in stock funds and long-term investments, vs $0.17 consensus. Co raises Q4 rev guidance, sees revs of $48-51 mln vs $48.16 mln consensus; which represents a 37% to 45% y/y increase in fourth quarter net revenue.

8:00AM Best Buy narrows FY09 guidance; reports Dec revenue of $7.5 bln, market share gains (BBY) 29.65 : Best Buy updates its FY09 (ends Feb) EPS guidance to $2.50-2.70, which excludes the $111 mln investment impairment charge taken during Q3 (Nov) and any other restructuring charges to streamline operations in preparation for a challenging fiscal 2010 environment. This new guidance represents a narrowing of its prior range of $2.30-2.90. Consensus is $2.61. The guidance assumes a comparable store sales decline of 2-3% for FY09. Co also reported that December revenue rose 4% to $7.5 bln, which was in line with company expectations. Gains from the inclusion of Best Buy Europe's revenue and the net addition of 194 new stores were largely offset by a 6.5% decline in comparable store sales and the unfavorable impact of fluctuations in foreign currency exchange rates. Co says "While the environment continues to be as challenging as we expected, consumers are being drawn to brands that they trust, and they are responding to our customer-centric model. In this light, we believe the market share gains we've been making will be sustained."

7:07AM Emergent Biosolutions lowers FY08, FY09 rev guidance; sees FY09 revs of $225-240 mln vs $240.43 First Call Consensus (EBS) 25.79 : Co issues downside guidance for FY08 (Dec), sees FY08 (Dec) revs of $179 vs. $187.23 mln First Call consensus; co notes An additional $12 mln of BioThrax revenue originally planned for the fourth quarter of 2008 is expected to be recognized in 1Q 2009. Co issues downside guidance for FY09 (Dec), sees FY09 (Dec) revs of $225-240 vs. $240.43 mln consensus; For 2009, co is forecasting 25% to 35% growth in total revenue.

6:41AM ICON plc sees FY09 EPS of $1.40-1.52 vs. $1.55 First Call consensus; guides down for FY09 (Dec) revs, sees $930-980 vs. $1.03 bln consensus (ICLR) 20.46 : Co issues guidance for FY09 (Dec), sees EPS of $1.40-1.52 vs. $1.55 First Call consensus; issues downside guidance for FY09 (Dec) revs; sees $930-980 vs. $1.03 bln consensus.

6:34AM Donnelley & Sons guides below consensus for Q4 (RRD) 15.04 : Co issuesdownside guidance for Q4 (Dec), sees EPS of $0.51-0.61, excluding non-recurring items, vs. $0.78 First Call consensus. Board of Directors declares a regular quarterly dividend of 26 cents per common share and currently plans to maintain present quarterly dividend. "We believe that the rate of economic change remains elevated... As a consequence of the unpredictable global environment and its potential impacts on competitors and customers, we do not expect to provide full-year earnings per share guidance for 2009 on our February 25 conference call. However, we look forward to providing detail behind our strategic and operational plans at that time."

5:11AM AZZ Inc. beats by $0.07, misses on revs; guides FY09 EPS above consensus, revs in-line (AZZ) : Reports Q3 (Nov) earnings of $0.88 per share, $0.07 better than the First Call consensus of $0.81; revenues rose 25.8% year/year to $108.9 mln vs the $113 mln consensus. Co issues mixed guidance for FY09, sees EPS of $3.35-3.45 vs. $3.23 consensus; sees FY09 revs of $420.0-430.0 mln vs. $423.11 mln consensus.